The North America Nucleic Acid Isolation and Purification Market would witness market growth of 8.5% CAGR during the forecast period (2023-2030).
Automation is a significant trend in nucleic acid isolation and purification. Automated systems and robotics are increasingly being employed to streamline and scale up extraction processes. High-throughput techniques allow the handling of larger sample volumes and facilitate rapid processing. Nanotechnology is being integrated into nucleic acid isolation methods. This involves using nanomaterials and nanodevices, such as nanoparticles and nanofluidic systems, to capture, manipulate, and purify nucleic acids at a nanoscale level.
The applications of these techniques are broad and diverse. In research, these methods are employed in genomics, transcriptomics, epigenetics, and metagenomics. They are instrumental in understanding the structure and function of genes, RNA, DNA, and their modifications. In clinical diagnostics, these techniques are pivotal in identifying genetic mutations, pathogens, and other disease-associated biomarkers. These methods are crucial in the development of personalized medicine, where the understanding of an individual’s genetic makeup aids in customizing treatments.
North America is a hub for biotech start-ups. Companies like CRISPR Therapeutics and Editas Medicine, focusing on gene editing technologies, have attracted significant venture capital and investment for advancing their R&D in gene therapy and genetic diseases. Medtronic, a medical device company, has its R&D headquarters in North America and invests in developing advanced medical technologies. Therefore, rising research and development activities in North America will boost the demand in the regional market.
The US market dominated the North America Nucleic Acid Isolation and Purification Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $3,027.8 million by 2030. The Canada market is experiencing a CAGR of 10.9% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 9.9% during (2023 - 2030).
Based on Application, the market is segmented into Diagnostics, Drug Discovery & Development, Agriculture & Animal Research, and Personalized Medicine & Others. Based on Product, the market is segmented into Reagents, Kits, and Instruments. Based on Method, the market is segmented into Magnetic Beads, Column Based, Reagent Based, and Others. Based on Type, the market is segmented into Plasmid DNA Isolation & Purification, Total RNA Isolation & Purification, Circulating Nucleic Acid Isolation & Purification, Genomic DNA Isolation & Purification, Messenger RNA Isolation & Purification, microRNA Isolation & Purification, and Others. Based on End User, the market is segmented into Hospitals & Diagnostic Centres, Pharmaceutical & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Nucleic Acid Isolation and Purification Market is Predict to reach $11.5 Billion by 2030, at a CAGR of 9.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd., Merck KGaA, Promega Corporation, Agilent Technologies, Inc., Danaher Corporation, Bio-Rad laboratories, Inc., Illumina, Inc., and New England Biolabs, Inc.
By Application
By Product
By Method
By Type
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
